Sun, Mar 1, 2015, 3:08 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • riskybiz1111 riskybiz1111 May 20, 2013 8:14 AM Flag

    Lipitor Alert! What Do Medivation And AtheroNova Have In Common?

    Medivation Inc. (NASDAQ: MDVN) is a classic Wall Street success story. Founded by a group of experienced professionals, the company acquired early stage pharmaceuticals and medical devices that had promising clinical, intellectual property and commercial prospects and grew from just $5.00 per share in 2010 to nearly $60.00 per share three years later. The majority of this growth happened in late 2011/early 2012, when the stock appreciated nearly 500% after successful clinical trials unlocked significant value in its product pipeline. [1]
    Behind the scenes of this success, was biotech investment fund manager Fred Knoll, via his firm Knoll Capital Management, as a key investor. The fund began building a stake in the company in early 2006, where it acquired about $7.2 million worth of stock, according to regulatory filings. By the same time in 2007, the fund had increased its share ownership and the $66 million position became the largest in its portfolio. And, according to the fund’s most recent regulatory filings, the stake is now worth more than $130 million today. [2]
    Taking a New Biotech Under the Wing
    Fred Knoll may be interested in another unique biotech play, based on his involvement in a fund called Europa International Inc. With Knoll Capital Management as an advisor, Europa International acquired a shell holding company that reverse merged with a biotech company called AtheroNova Inc. (OTCQB: AHRO) to take it public. The stock has since been quietly trading – much like Medivation – whilst pursuing clinical trials. If Mr. Knoll is right about this company, as he was with Medivation, the stock could see significant upside from these levels. [2]
    AtheroNova’s most advanced candidate, AHRO-001, is a proprietary compound administered via tablet that dissolves plaque within arterial walls, through a process known as delipidization, and then safely remove it from the body using a natural metabolic process. With the s

34.32-0.27(-0.78%)Feb 27 4:01 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Aruba Networks, Inc.
NASDAQFri, Feb 27, 2015 4:00 PM EST
Flamel Technologies SA
NASDAQFri, Feb 27, 2015 4:00 PM EST